CLINICAL_TRIALS
trial_result
· 2024-11-12
Clinical Trial Update: Glyburide (RP-1127) for Traumatic Brain Injury (TBI) [Phase 2]
Summary
Phase 2 trial of glyburide (RP-1127) for traumatic brain injury has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Remedy Pharmaceuticals, Inc. | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED